IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
July 22, 2022 16:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market...
IRADIMED Names John F. Glenn Chief Financial Officer
May 26, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before...
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
April 29, 2022 07:00 ET
|
iRadimed Corporation
Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial...
IRADIMED CORPORATION Announces Executive Transition
April 28, 2022 16:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has...
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
April 05, 2022 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market...
IRADIMED Announces Special $1.00 Per Share Cash Dividend
February 07, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share...
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
February 04, 2022 07:00 ET
|
iRadimed Corporation
Reports fourth quarter 2021 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33Announces full-year and first quarter 2022 financial guidance WINTER SPRINGS, Fla.,...
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
January 20, 2022 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
October 29, 2021 07:00 ET
|
iRadimed Corporation
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29,...
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
October 08, 2021 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market...